Ride fundraising drives cutting-edge CAR T therapy at Roswell Park

At Roswell Park Comprehensive Cancer Center, scientists and clinicians are serious about finding the next cancer treatments today. With Ride for Roswell fundraising dollars behind them, they can urgently pursue the research and clinical trials that will become lifesaving standard-of-care treatments.

Your fundraising supports research at Roswell Park surrounding CAR T-cell therapy, a form of immunotherapy that uses reengineered cells to teach your body to fight its own cancer. This advancement was developed originally for blood cancers, but researchers are hard at work to apply this method to solid tumors, as well.

Roswell Park has been developing novel uses for CAR T-cell therapy, enhancing scientific discoveries that can change the way we treat cancer.

Expanding the way we can use this type of treatment will mean being able to reach more and more patients who are in need of some light in a difficult time. Patients whose treatments have maybe not provided the results they were hoping to see because of their particular makeup or type of cancer.



Renier Brentjens, MD, PhD
Marco Davila, MD, PhD
Photo of Bud

Some patients have already experienced the hope that CAR T therapy can provide. Patients like Bernard “Bud” Blocho have been given more time with their loved ones thanks to this cutting-edge science.

Bud is a devoted husband, dad and grandpa who has Hodgkin’s and non-Hodgkin’s lymphoma. When cancer returned after years in remission, Bud ultimately needed CAR T therapy at Roswell Park to rid his body of cancer once again.

Thanks to Ride for Roswell donors and participants, patients like Bud can spend more time enjoying their families and less time fighting cancer.